Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00239603 · ClinicalTrials.gov registry record
Efficacy Study of the OV-Watch™ Personal Fertility Monitor for Women Using Clomiphene Citrate.
A clinical trial, sponsored by Emory University.
- Completed
- Registry status
- 40
- Enrollment target
NCT00239603: Completed study, sponsored by Emory University.
NCT00239603 is a clinical trial that has completed, run by Emory University. The registered enrollment target is 40 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00239603 has completed, sponsored by Emory University.
- COMPLETED
- Registry status
- 40 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the effectiveness of the OV-Watch to predict ovulation while women are taking clomiphene citrate.
Interventions
- DEVICE OV-Watch
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2005-10 |
| Est. Completion | 2007-06 |
What the finished NCT00239603 record still lists
NCT00239603 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 40 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which OV-Watch is the first listed.
NCT00239603 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00239603 about?
NCT00239603 is a clinical study titled "Efficacy Study of the OV-Watch™ Personal Fertility Monitor for Women Using Clomiphene Citrate.". The purpose of this study is to evaluate the effectiveness of the OV-Watch to predict ovulation while women are taking clomiphene citrate.
What is the current status of trial NCT00239603?
This trial is currently completed. The enrollment target is 40 participants. The study started on 2005-10. Estimated completion is 2007-06.
What interventions are being tested in trial NCT00239603?
The interventions under investigation include: OV-Watch (DEVICE).
Who is sponsoring clinical trial NCT00239603?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia